Best Peptide Sample Programs 2026: 9 Discounted First-Month Deals, Ranked

Four factors: (1) first-month price (Hone + Henry Meds at $99 lead the field), (2) what's included in the sample (consult, medication, supplies, lab interpretation), (3) clinical depth (specialty clinics include broader baseline labs at higher first-month cost but better clinical fit for complex cases), (4) ongoing pricing transparency after the sample period. Telehealth bundles win on accessibility; specialty intakes win on depth.

Most patients should start with a telehealth sample bundle (Hone $99, Henry Meds $99, Eden $129) for the sermorelin + ipamorelin starter combo. Graduate to a specialty-clinic intake (Marek $300-600, Defy $250-500, LIVV concierge) when (a) your protocol becomes complex — peptide stacks, GH secretagogues, hormone integration, (b) you want extensive ancillary therapies, or (c) the lower-tier provider can't handle your specific clinical situation.

Marek's $300-600 intake includes the deepest peptide formulary on the US clinical track — sermorelin, ipamorelin, CJC-1295 (with and without DAC), GHK-Cu, thymosin alpha-1, plus integrated TRT — with physician-led protocol design, lab-first intake, and direct 503A pharmacy relationships. The intake is the sample; what you get back per dollar is the strongest in the specialty tier. The $200-450/month ongoing reflects the depth.

Both are on the FDA Category 2 list and prohibited from 503A compounding — no legitimate clinical sample program exists for either molecule in the US. Marek, Defy, and the rest can have a clinical conversation about legitimate alternative samples (GHK-Cu sample, sermorelin + ipamorelin starter combo) if your interest is in the indications BPC-157 / TB-500 are researched for. We do not link to research-chemical vendors regardless of their RUO disclaimers.